Cannabis use in adolescence and risk of psychosis: Are there factors that moderate this relationship? A systematic review and meta-analysis

References

• United Nations Office on Drug and Crime (UNODC). World drug report 2020: drug use and health consequences. United Nations Publication, Sales No. E20.XI.6. https://wdr.unodc.org. Accessed July 24, 2020.
   Google Scholar
• Peacock A, Leung J, Larney S, et al. Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction. 2018;113(10):1905–1926.
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Charlson F, Ferrari A, et al. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry. 2018;5(12):987–1012.
   PubMed Web of Science ®Google Scholar
• Green B, Young R, Kavanagh D. Cannabis use and misuse prevalence among people with psychosis. Br J Psychiatry. 2005;187:306–313.
   PubMed Web of Science ®Google Scholar
• Charlson FJ, Ferrari AJ, Santomauro DF, et al. Global epidemiology and burden of schizophrenia: findings from the global burden of disease study 2016. Schizophr Bull. 2018;44(6):1195–1203.
   PubMed Web of Science ®Google Scholar
• Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet. 2016;388(10039):86–97.
   PubMed Web of Science ®Google Scholar
• Malone DT, Hill MN, Rubino T. Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models. Br J Pharmacol. 2010;160(3):511–522.
   PubMed Web of Science ®Google Scholar
• Schneider M. Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure. Addict Biol. 2008;13(2):253–263.
   PubMed Web of Science ®Google Scholar
• Keshavan MS, Giedd J, Lau JYF, Lewis DA, Paus T. Changes in the adolescent brain and the pathophysiology of psychotic disorders. Lancet Psychiatry. 2014;1(7):549–558.
   PubMed Web of Science ®Google Scholar
• Ashton CH. Pharmacology and effects of cannabis: a brief review. Br J Psychiatry. 2001;178:101–106.
   PubMed Web of Science ®Google Scholar
• Chadwick B, Miller ML, Hurd YL. Cannabis use during adolescent development: susceptibility to psychiatric illness. Front Psychiatry. 2013;4:129.
   PubMedGoogle Scholar
• Casadio P, Fernandes C, Murray RM, Di Forti M. Cannabis use in young people: the risk for schizophrenia. Neurosci Biobehav Rev. 2011;35(8):1779–1787.
   PubMed Web of Science ®Google Scholar
• Bagot KS, Milin R, Kaminer Y. Adolescent initiation of cannabis use and early-onset psychosis. Subst Abus. 2015;36(4):524–533.
   PubMed Web of Science ®Google Scholar
• Lorenzetti V, Alonso-Lana S, Youssef GJ, et al. Adolescent cannabis use: what is the evidence for functional brain alteration? Curr Pharm Des. 2016;22(42):6353–6365.
   PubMed Web of Science ®Google Scholar
• Murray RM, Di Forti M. Cannabis and psychosis: What degree of proof do we require? Biol Psychiatry. 2016;79(7):514–515.
   PubMed Web of Science ®Google Scholar
• Nielsen SM, Toftdahl NG, Nordentoft M, Hjorthøj C. Association between alcohol, cannabis, and other illicit substance abuse and risk of developing schizophrenia: a nationwide population based register study. Psychol Med. 2017;47(9):1668–1677.
   PubMed Web of Science ®Google Scholar
• D'Souza DC, Radhakrishnan R, Sherif M, et al. Cannabinoids and psychosis. Curr Pharm Des. 2016;22(42):6380–6391.
   PubMed Web of Science ®Google Scholar
• Griffith‐Lendering MFH, Wigman JTW, van Leeuwen AP, et al. Cannabis use and vulnerability for psychosis in early adolescence—a TRAILS study. Addiction. 2013;108(4):733–740.
   PubMed Web of Science ®Google Scholar
• Gage SH, Jones HJ, Burgess S, et al. Assessing causality in associations between cannabis use and schizophrenia risk: a two-sample Mendelian randomization study. Psychol Med. 2017;47(5):971–980.
   PubMed Web of Science ®Google Scholar
• Ksir C, Hart CL. Cannabis and psychosis: a critical overview of the relationship. Curr Psychiatry Rep. 2016;18(2):1–11.
   PubMed Web of Science ®Google Scholar
• Power RA, Verweij KJH, Zuhair M, et al. Genetic predisposition to schizophrenia associated with increased use of cannabis. Mol Psychiatry. 2014;19(11):1201–1204.
   PubMed Web of Science ®Google Scholar
• Gage SH, Zammit S, Hickman M. Stronger evidence is needed before accepting that cannabis plays an important role in the aetiology of schizophrenia in the population. F1000 Med Rep. 2013;5(1):2–5.
   PubMedGoogle Scholar
• Gomes FV, Rincón-Cortés M, Grace AA. Adolescence as a period of vulnerability and intervention in schizophrenia: Insights from the MAM model. Neurosci Biobehav Rev. 2016;70:260–270.
   PubMed Web of Science ®Google Scholar
• Parolaro D. Adolescent cannabis consumption and schizophrenia: epidemiological and experimental evidences. Adicciones. 2010;22(3):185–190.
   PubMed Web of Science ®Google Scholar
• Parakh P, Basu D. Cannabis and psychosis: have we found the missing links? Asian J Psychiatr. 2013;6(4):281–287.
   PubMedGoogle Scholar
• Bagot KS, Chang A. Marijuana and psychosis: policy implications for treatment providers. J Am Acad Child Adolesc Psychiatry. 2018;57(8):613–614.
   PubMed Web of Science ®Google Scholar
• Wright A, Cather C, Gilman J, Evins AE. The changing legal landscape of cannabis use and its role in youth-onset psychosis. Child Adolesc Psychiatr Clin N Am. 2020;29(1):145–156.
   PubMed Web of Science ®Google Scholar
• Moore THM, Zammit S, Lingford-Hughes A, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007;370(9584):319–328.
   PubMed Web of Science ®Google Scholar
• Semple DM, McIntosh AM, Lawrie SM. Cannabis as a risk factor for psychosis: systematic review. J Psychopharmacol. 2005;19(2):187–194.
   PubMed Web of Science ®Google Scholar
• Marconi A, Di Forti M, Lewis CM, Murray RM, Vassos E. Meta-Analysis of the association between the level of cannabis use and risk of psychosis. Schizophr Bull. 2016;42(5):1262–1269.
   PubMed Web of Science ®Google Scholar
• Hosseini S, Oremus M. The effect of age of initiation of cannabis use on psychosis, depression, and anxiety among youth under 25 years. Can J Psychiatry. 2019;64(5):304–312.
   PubMed Web of Science ®Google Scholar
• van der Steur SJ, Batalla A, Bossong MG. Factors moderating the association between cannabis use and psychosis risk: a systematic review. Brain Sci. 2020;10(2):97.
   Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
   PubMed Web of Science ®Google Scholar
• Garrard J. 2017. Health Sciences Literature Review Made Easy: The Matrix Method. Burlington, MA: Jones and Bartlett Learning.
   Google Scholar
• Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:4–10.
   Google Scholar
• Jones JD, Calkins ME, Scott JC, Bach EC, Gur RE. Cannabis use, polysubstance use, and psychosis spectrum symptoms in a community-based sample of U.S. youth. J Adolesc Health. 2017;60(6):653–659.
   PubMed Web of Science ®Google Scholar
• Kosty DB, Seeley JR, Farmer RF, Stevens JJ, Lewinsohn PM. Trajectories of cannabis use disorder: risk factors, clinical characteristics and outcomes. Addiction. 2017;112(2):279–287.
   PubMed Web of Science ®Google Scholar
• Levy S, Weitzman ER. Acute mental health symptoms in adolescent marijuana users. JAMA Pediatr. 2019;173(2):185–186.
   PubMed Web of Science ®Google Scholar
• Ryan JE, Veliz P, McCabe SE, Stoddard SA, Boyd CJ. Association of early onset of cannabis, cigarette, other drug use and schizophrenia or psychosis. Schizophr Res. 2020;215:482–484.
   PubMed Web of Science ®Google Scholar
• Auther AM, McLaughlin D, Carrión RE, Nagachandran P, Correll CU, Cornblatt BA. Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome. Psychol Med. 2012;42(12):2485–2497.
   PubMed Web of Science ®Google Scholar
• Auther AM, Cadenhead KS, Carrión RE, et al. Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample. Acta Psychiatr Scand. 2015;132(1):60–68.
   PubMed Web of Science ®Google Scholar
• Bechtold J, Simpson T, White HR, Pardini D. Chronic adolescent marijuana use as a risk factor for physical and mental health problems in young adult men. Psychol Addict Behav. 2015;29(3):552–563.
   PubMed Web of Science ®Google Scholar
• Bechtold J, Hipwell A, Lewis DA, Loeber R, Pardini D. Concurrent and sustained cumulative effects of adolescent marijuana use on subclinical psychotic symptoms. Am J Psychiatry. 2016;173(8):781–789.
   PubMed Web of Science ®Google Scholar
• Day NL, Goldschmidt L, Day R, Larkby C, Richardson GA. Prenatal marijuana exposure, age of marijuana initiation, and the development of psychotic symptoms in young adults. Psychol Med. 2015;45(8):1779–1787.
   PubMed Web of Science ®Google Scholar
• Houston JE, Murphy J, Adamson G, Stringer M, Shevlin M. Childhood sexual abuse, early cannabis use, and psychosis: testing an interaction model based on the National Comorbidity Survey. Schizophr Bull. 2008;34(3):580–585.
   PubMed Web of Science ®Google Scholar
• Kantrowitz JT, Nolan KA, Sen S, Simen AA, Lachman HM, Bowers MBJ. Adolescent cannabis use, psychosis and catechol-O-methyltransferase genotype in African Americans and Caucasians. Psychiatr Q. 2009;80(4):213–218.
   PubMed Web of Science ®Google Scholar
• Mackie CJ, Castellanos-Ryan N, Conrod PJ. Developmental trajectories of psychotic-like experiences across adolescence: impact of victimization and substance use. Psychol Med. 2011;41(1):47–58.
   PubMed Web of Science ®Google Scholar
• Mackie CJ, O'Leary-Barrett M, Al-Khudhairy N, et al. Adolescent bullying, cannabis use and emerging psychotic experiences: A longitudinal general population study. Psychol Med. 2013;43(5):1033–1044.
   PubMed Web of Science ®Google Scholar
• Di Forti M, Sallis H, Allegri F, et al. Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users. Schizophr Bull. 2014;40(6):1509–1517.
   PubMed Web of Science ®Google Scholar
• Di Forti M, Marconi A, Carra E, et al. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study. Lancet Psychiatry. 2015;2(3):233–238.
   PubMed Web of Science ®Google Scholar
• Gage SH, Hickman M, Heron J, et al. Associations of cannabis and cigarette use with psychotic experiences at age 18: findings from the Avon Longitudinal Study of parents and children. Psychol Med. 2014;44(16):3435–3444.
   PubMed Web of Science ®Google Scholar
• Shakoor S, Zavos HMS, McGuire P, Cardno AG, Freeman D, Ronald A. Psychotic experiences are linked to cannabis use in adolescents in the community because of common underlying environmental risk factors. Psychiatry Res. 2015;227(2–3):144–151.
   PubMed Web of Science ®Google Scholar
• Jones HJ, Gage SH, Heron J, et al. Association of combined patterns of tobacco and cannabis use in adolescence with psychotic experiences. JAMA Psychiatry. 2018;75(3):240–246.
   PubMed Web of Science ®Google Scholar
• Zammit S, Owen MJ, Evans J, Heron J, Lewis G. Cannabis, COMT and psychotic experiences. Br J Psychiatry. 2011;199(5):380–385.
   PubMed Web of Science ®Google Scholar
• Paruk S, Burns JK, Caplan R. Cannabis use and family history in adolescent first episode psychosis in Durban, South Africa. J Child Adolesc Ment Health. 2013;25(1):61–68.
   PubMedGoogle Scholar
• Paruk S, Jhazbhay K, Singh K, Sartorius B, Burns JK. A comparative study of socio-demographic and substance use correlates in early-onset psychosis. Early Interv Psychiatry. 2018;12(3):339–347.
   PubMed Web of Science ®Google Scholar
• Di Forti M, Quattrone D, Freeman TP, et al. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. Lancet Psychiatry. 2019;6(5):427–436.
   PubMed Web of Science ®Google Scholar
• Quattrone D, Ferraro L, Tripoli G, et al. Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study. Psychol Med. 2020:1–9. DOI:https://doi.org/10.1017/S0033291720000082. Online ahead of print.
   Google Scholar
• Leadbeater BJ, Ames ME, Linden-Carmichael AN. Age-varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression and anxiety in adolescents and adults. Addiction. 2019;114(2):278–293.
   PubMed Web of Science ®Google Scholar
• Konings M, Stefanis N, Kuepper R, et al. Replication in two independent population-based samples that childhood maltreatment and cannabis use synergistically impact on psychosis risk. Psychol Med. 2012;42(1):149–159.
   PubMed Web of Science ®Google Scholar
• Baeza I, Graell M, Moreno D, et al. Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-term outcome (CAFEPS study). Schizophr Res. 2009;113(2–3):129–137.
   PubMed Web of Science ®Google Scholar
• Setien-Suero E, Martinez-Garcia O, de la Foz V, et al. Age of onset of cannabis use and cognitive function in first-episode non-affective psychosis patients: outcome at three-year follow-up. Schizophr Res. 2018;201:159–166.
   PubMed Web of Science ®Google Scholar
• Andréasson S, Engström A, Allebeck P, Rydberg U. Cannabis and schizophrenia: a longitudinal study of Swedish conscripts. The Lancet. 1987;330(8574):1483–1486.
   Web of Science ®Google Scholar
• Manrique-Garcia E, Zammit S, Dalman C, Hemmingsson T, Andreasson S, Allebeck P. Cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort. Psychol Med. 2012;42(6):1321–1328.
   PubMed Web of Science ®Google Scholar
• Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ. 2002;325(7374):1199–1199.
   PubMed Web of Science ®Google Scholar
• Zammit S, Lewis G, Dalman C, Allebeck P. Examining interactions between risk factors for psychosis. Br J Psychiatry. 2010;197(3):207–211.
   PubMed Web of Science ®Google Scholar
• Bourque J, Afzali MH, O'Leary-Barrett M, Conrod P. Cannabis use and psychotic-like experiences trajectories during early adolescence: the coevolution and potential mediators. J Child Psychol Psychiatry. 2017;58(12):1360–1369.
   PubMed Web of Science ®Google Scholar
• Mustonen A, Niemelä S, Nordström T, Murray GK, Mäki P, Jääskeläinen E. Adolescent cannabis use, baseline prodromal symptoms and the risk of psychosis. Br J Pschiatry. 2018;212(4):227–233.
   PubMed Web of Science ®Google Scholar
• Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ. 2002;325(7374):1212–1213.
   PubMed Web of Science ®Google Scholar
• Fergusson DM, Horwood LJ, Swain-Campbell NR. Cannabis dependence and psychotic symptoms in young people. Psychol Med. 2003;33(1):15–21.
   PubMed Web of Science ®Google Scholar
• Caspi A, Moffitt TE, Cannon M, et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry. 2005;57(10):1117–1127.
   PubMed Web of Science ®Google Scholar
• Henquet C, Krabbendam L, Spauwen J, et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ. 2005;330(7481):11.
   PubMed Web of Science ®Google Scholar
• Kuepper R, van Os J, Lieb R, Wittchen H-U, Henquet C. Do cannabis and urbanicity co-participate in causing psychosis? Evidence from a 10-year follow-up cohort study. Psychol Med. 2011;41(10):2121–2129.
   PubMed Web of Science ®Google Scholar
• Kuepper R, van Os J, Lieb R, Wittchen H-U, Höfler M, Henquet C. Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. BMJ. 2011;342:d738.
   PubMed Web of Science ®Google Scholar
• McGrath J, Welham J, Scott J, et al. Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults. Arch Gen Psychiatry. 2010;67(5):440–447.
   PubMed Web of Science ®Google Scholar
• Valmaggia LR, Day FL, Jones C, et al. Cannabis use and transition to psychosis in people at ultra-high risk. Psychol Med. 2014;44(12):2503–2512.
   PubMed Web of Science ®Google Scholar
• Miettunen J, Törmänen S, Murray GK, et al. Association of cannabis use with prodromal symptoms of psychosis in adolescence. Br J Psychiatry. 2008;192(6):470–471.
   PubMed Web of Science ®Google Scholar
• Lodhi RJ, Wang Y, Rossolatos D, et al. Investigation of the COMT Val158Met variant association with age of onset of psychosis, adjusting for cannabis use. Brain Behav. 2017;7(11):e00850.
   PubMed Web of Science ®Google Scholar
• Schubart CD, Van Gastel WA, Breetvelt EJ, et al. Cannabis use at a young age is associated with psychotic experiences. Psychol Med. 2011;41(6):1301–1310.
   PubMed Web of Science ®Google Scholar
• Schimmelmann BG, Conus P, Cotton SM, et al. Cannabis use disorder and age at onset of psychosis–a study in first-episode patients. Schizophr Res. 2011;129(1):52–56.
   PubMed Web of Science ®Google Scholar
• Konings M, Henquet C, Maharajh HD, Hutchinson G, Van Os J. Early exposure to cannabis and risk for psychosis in young adolescents in Trinidad. Acta Psychiatr Scand. 2008;118(3):209–213.
   PubMed Web of Science ®Google Scholar
• van Gastel WA, Wigman JTW, Monshouwer K, et al. Cannabis use and subclinical positive psychotic experiences in early adolescence: findings from a Dutch survey. Addiction. 2012;107(2):381–387.
   PubMed Web of Science ®Google Scholar
• Madraisau S, Tomoichi U, Ord LM, et al. Early signs and symptoms of psychosis among Palauan adolescents. Early Interv Psychiatry. 2010;4(2):153–161.
   PubMed Web of Science ®Google Scholar
• Ringen PA, Nesvåg R, Helle S, et al. Premorbid cannabis use is associated with more symptoms and poorer functioning in schizophrenia spectrum disorder. Psychol Med. 2016;46(15):3127–3136.
   PubMed Web of Science ®Google Scholar
• Scott J, Martin G, Bor W, Sawyer M, Clark J, McGrath J. The prevalence and correlates of hallucinations in Australian adolescents: results from a national survey. Schizophr Res. 2009;107(2–3):179–185.
   PubMed Web of Science ®Google Scholar
• Stefanis NC, Dragovic M, Power BD, Jablensky A, Castle D, Morgan VA. Age at initiation of cannabis use predicts age at onset of psychosis: the 7- to 8-year trend. Schizophr Bull. 2013;39(2):251–254.
   PubMed Web of Science ®Google Scholar
• Hides L, Lubman DI, Buckby J, et al. The association between early cannabis use and psychotic-like experiences in a community adolescent sample. Schizophr Res. 2009;112(1–3):130–135.
   PubMed Web of Science ®Google Scholar
• Colins O, Vermeiren R, Vreugdenhil C, Schuyten G, Broekaert E, Krabbendam A. Are psychotic experiences among detained juvenile offenders explained by trauma and substance use? Drug Alcohol Depend. 2009;100(1–2):39–46.
   PubMed Web of Science ®Google Scholar
• Alibrahim O, Elawad N, Misau YA, Shaikh TM, Allam N. Drug dependence and psychotic symptoms: a retrospective study of adolescents who abuse drugs at Al-Amal Hospital in Jeddah, Saudi Arabia. J Public Health Afr. 2012;3(1):e5.
   PubMedGoogle Scholar
• Stefanis NC, Delespaul P, Henquet C, et al. Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction. 2004;99(10):1333–1341.
   PubMed Web of Science ®Google Scholar
• Dolphin L, Dooley B, Fitzgerald A. Prevalence and correlates of psychotic like experiences in a nationally representative community sample of adolescents in Ireland. Schizophr Res. 2015;169(1–3):241–247.
   PubMed Web of Science ®Google Scholar
• Estrada G, Fatjó-Vilas M, Muñoz MJ, et al. Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism. Acta Psychiatr Scand. 2011;123(6):485–492.
   PubMed Web of Science ®Google Scholar
• Harley M, Kelleher I, Clarke M, et al. Cannabis use and childhood trauma interact additively to increase the risk of psychotic symptoms in adolescence. Psychol Med. 2010;40(10):1627–1634.
   PubMed Web of Science ®Google Scholar
• Hodgins S, Larm P, Westerman J. Individuals developing schizophrenia are hidden among adolescent substance misusers. Psychol Med. 2016;46(14):3041–3050.
   PubMed Web of Science ®Google Scholar
• Mané A, Bergé D, Penzol MJ, PEPs Group, et al. Cannabis use, COMT, BDNF and age at first-episode psychosis. Psychiatry Res. 2017;250:38–43.
   PubMed Web of Science ®Google Scholar
• Barrigón ML, Gurpegui M, Ruiz-Veguilla M, et al. Temporal relationship of first-episode non-affective psychosis with cannabis use: a clinical verification of an epidemiological hypothesis. J Psychiatr Res. 2010;44(7):413–420.
   PubMed Web of Science ®Google Scholar
• Fonseca-Pedrero E, Lucas-Molina B, Pérez-Albéniz A, Inchausti F, Ortuño-Sierra J. Psychotic-like experiences and cannabis use in adolescents from the general population. Adicciones. 2020;32(1):41–51.
   PubMed Web of Science ®Google Scholar
• Houston JE, Murphy J, Shevlin M, Adamson G. Cannabis use and psychosis: re-visiting the role of childhood trauma. Psychol Med. 2011;41(11):2339–2348.
   PubMed Web of Science ®Google Scholar
• Roncero C, Palma-Álvarez RF, Barrau V, Servicio de Psiquiatría, Complejo Asistencial Universitario de Salamanca (CAUSA), Instituto de Biomedicina de Salamanca (IBSAL), Universidad de Salamanca, Salamanca, España, et al. Early cannabis use and its relation to the development of psychiatric disorders: a review. SM. 2017;40(6):291–298.
   Google Scholar
• Baudin G, Godin O, Lajnef M, FondaMental Academic Centers of Expertise for Schizophrenia (FACE-SZ) Collaborators, et al. Differential effects of childhood trauma and cannabis use disorders in patients suffering from schizophrenia. Schizophr Res. 2016;175(1–3):161–167.
   PubMed Web of Science ®Google Scholar
• Mills R, Kisely S, Alati R, Strathearn L, Najman JM. Child maltreatment and cannabis use in young adulthood: a birth cohort study. Addiction. 2017;112(3):494–501.
   PubMed Web of Science ®Google Scholar
• Coughlan H, Cannon M. Does childhood trauma play a role in aetiology of psychosis? A review of recent evidence. BJPsych Advances. 2017;23(5):307–317.
   Google Scholar
• `Gurillo P, Jauhar S, Murray RM, Maccabe JH. Does tobacco use cause psychosis? Systematic review and meta-analysis. Lancet Psychiatry. 2015;2(8):718–725.
   PubMed Web of Science ®Google Scholar
• Agrawal A, Lynskey MT. Cannabis controversies: how genetics can inform the study of comorbidity. Addiction. 2014;109(3):360–370.
   PubMed Web of Science ®Google Scholar
• Vaessen TSJ, De Jong L, Schäfer AT, et al. The interaction between cannabis use and the Val158Met polymorphism of the COMT gene in psychosis: A transdiagnostic meta ± analysis. PLOS One. 2018;13(2):e0192658–22.
   PubMed Web of Science ®Google Scholar
• Gage SH, Hickman M, Zammit S. Association between cannabis and psychosis: Epidemiologic evidence. Biol Psychiatry. 2016;79(7):549–556.
   PubMed Web of Science ®Google Scholar